Pre‐Existing Diabetes Alters Pulmonary Inflammatory Gene Expression Priming for Injury
The FASEB Journal · 2025
DOI: 10.1096/fj.202500816r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Abdulaziz H Alanazi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Experimental Therapeutics, University of Georgia, Augusta, Georgia, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Acute Lung Injury, Pneumonia, Gene Expression Regulation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Georgia Wilson Pharmacy Foundation, NEI NIH HHS, NCATS NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes mellitus (DM) is a systemic disease known for its cardiovascular complications, but its impact on pulmonary health remains underexplored. We aimed to determine how pre‐existing DM influences lung inflammation and susceptibility to acute lung injury (ALI). RNA sequencing was performed on lung tissues from streptozotocin‐induced DM and non‐DM mouse lungs, followed by gene enrichment and bioinformatics analysis. Lung inflammation and injury were assessed in a lipopolysaccharide‐induced sepsis model using Wet/Dry lung weight ratios, histopathology, RT‐qPCR, and cytokine profiling. Transcriptomic analysis revealed that DM lungs exhibited upregulated inflammatory pathways and signs of compromised endothelial barrier integrity. While LPS exposure induced lung inflammation, no additive or synergistic effect of DM and LPS was observed in exacerbating lung injury. However, DM alone was associated with increased expression of inflammatory cytokines (TNF‐α, IL‐1β, MCP‐1, and CXCL‐1), greater fluid accumulation, and structural lung changes indicative of enhanced baseline susceptibility to ALI. These findings underscore the impact of DM on priming the lung for inflammation and injury and suggest that targeting DM‐associated molecular pathways may help mitigate pulmonary complications in diabetic individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical and Experimental Therapeutics, University of Georgia, Augusta, Georgia, USA.
- Charlie Norwood VA Medical Center, Augusta, Georgia, USA.
- Department of Clinical Practice, College of Pharmacy, Northern Border University, Rafha, Saudi Arabia.
ORCID-Profile: Duo Zhang, Payaningal R Somanath
Förderung
- University of Georgia Wilson Pharmacy Foundation
- NEI NIH HHS
- NCATS NIH HHS
- Kenneth L. Waters Foundation
- HHS|NIH|National Center for Advancing Translational Sciences (NCATS)
- National Center for Advancing Translational Sciences
Zitieren
APA
Alanazi, A. H., Selim, M. S., Liu, F., Zhang, D., Narayanan, S. P., & Somanath, P. R. (2025). Pre‐Existing Diabetes Alters Pulmonary Inflammatory Gene Expression Priming for Injury. The FASEB Journal. https://doi.org/10.1096/fj.202500816r
Vancouver
Alanazi AH, Selim MS, Liu F, Zhang D, Narayanan SP, Somanath PR. Pre‐Existing Diabetes Alters Pulmonary Inflammatory Gene Expression Priming for Injury. The FASEB Journal. 2025. doi:10.1096/fj.202500816r
BibTeX
@article{Alanazi2025,
author = {Alanazi, Abdulaziz H and Selim, Mohamed S and Liu, Fang and Zhang, Duo and Narayanan, S Priya and Somanath, Payaningal R},
title = {Pre‐Existing Diabetes Alters Pulmonary Inflammatory Gene Expression Priming for Injury},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202500816r}
}
EUVIMED